603 related articles for article (PubMed ID: 17486044)
1. Small molecules enhance autophagy and reduce toxicity in Huntington's disease models.
Sarkar S; Perlstein EO; Imarisio S; Pineau S; Cordenier A; Maglathlin RL; Webster JA; Lewis TA; O'Kane CJ; Schreiber SL; Rubinsztein DC
Nat Chem Biol; 2007 Jun; 3(6):331-8. PubMed ID: 17486044
[TBL] [Abstract][Full Text] [Related]
2. Small molecule enhancers of rapamycin-induced TOR inhibition promote autophagy, reduce toxicity in Huntington's disease models and enhance killing of mycobacteria by macrophages.
Floto RA; Sarkar S; Perlstein EO; Kampmann B; Schreiber SL; Rubinsztein DC
Autophagy; 2007; 3(6):620-2. PubMed ID: 17786022
[TBL] [Abstract][Full Text] [Related]
3. Xyloketal-derived small molecules show protective effect by decreasing mutant Huntingtin protein aggregates in Caenorhabditis elegans model of Huntington's disease.
Zeng Y; Guo W; Xu G; Wang Q; Feng L; Long S; Liang F; Huang Y; Lu X; Li S; Zhou J; Burgunder JM; Pang J; Pei Z
Drug Des Devel Ther; 2016; 10():1443-51. PubMed ID: 27110099
[TBL] [Abstract][Full Text] [Related]
4. A rational mechanism for combination treatment of Huntington's disease using lithium and rapamycin.
Sarkar S; Krishna G; Imarisio S; Saiki S; O'Kane CJ; Rubinsztein DC
Hum Mol Genet; 2008 Jan; 17(2):170-8. PubMed ID: 17921520
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies.
Sarkar S; Ravikumar B; Floto RA; Rubinsztein DC
Cell Death Differ; 2009 Jan; 16(1):46-56. PubMed ID: 18636076
[TBL] [Abstract][Full Text] [Related]
6. AUTEN-67 (Autophagy Enhancer-67) Hampers the Progression of Neurodegenerative Symptoms in a Drosophila model of Huntington's Disease.
Billes V; Kovács T; Hotzi B; Manzéger A; Tagscherer K; Komlós M; Tarnóci A; Pádár Z; Erdős A; Bjelik A; Legradi A; Gulya K; Gulyás B; Vellai T
J Huntingtons Dis; 2016 May; 5(2):133-47. PubMed ID: 27163946
[TBL] [Abstract][Full Text] [Related]
7. Degradation of misfolded proteins by autophagy: is it a strategy for Huntington's disease treatment?
Lin F; Qin ZH
J Huntingtons Dis; 2013; 2(2):149-57. PubMed ID: 25063512
[TBL] [Abstract][Full Text] [Related]
8. Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications.
Williams A; Jahreiss L; Sarkar S; Saiki S; Menzies FM; Ravikumar B; Rubinsztein DC
Curr Top Dev Biol; 2006; 76():89-101. PubMed ID: 17118264
[TBL] [Abstract][Full Text] [Related]
9. Lithium and autophagy.
Motoi Y; Shimada K; Ishiguro K; Hattori N
ACS Chem Neurosci; 2014 Jun; 5(6):434-42. PubMed ID: 24738557
[TBL] [Abstract][Full Text] [Related]
10. Caffeic acid reduces A53T α-synuclein by activating JNK/Bcl-2-mediated autophagy in vitro and improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson's disease.
Zhang Y; Wu Q; Zhang L; Wang Q; Yang Z; Liu J; Feng L
Pharmacol Res; 2019 Dec; 150():104538. PubMed ID: 31707034
[TBL] [Abstract][Full Text] [Related]
11. [A Therapeutic Target for Inhibition of Neurodegeneration: Autophagy].
Pupyshev AB; Korolenko TA; Tikhonova MA
Zh Vyssh Nerv Deiat Im I P Pavlova; 2016 Sep; 66(5):515-540. PubMed ID: 30695399
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin alleviates toxicity of different aggregate-prone proteins.
Berger Z; Ravikumar B; Menzies FM; Oroz LG; Underwood BR; Pangalos MN; Schmitt I; Wullner U; Evert BO; O'Kane CJ; Rubinsztein DC
Hum Mol Genet; 2006 Feb; 15(3):433-42. PubMed ID: 16368705
[TBL] [Abstract][Full Text] [Related]
13. Role of autophagy in the clearance of mutant huntingtin: a step towards therapy?
Ravikumar B; Rubinsztein DC
Mol Aspects Med; 2006; 27(5-6):520-7. PubMed ID: 16973207
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease.
Ravikumar B; Vacher C; Berger Z; Davies JE; Luo S; Oroz LG; Scaravilli F; Easton DF; Duden R; O'Kane CJ; Rubinsztein DC
Nat Genet; 2004 Jun; 36(6):585-95. PubMed ID: 15146184
[TBL] [Abstract][Full Text] [Related]
15. Huntington's disease: degradation of mutant huntingtin by autophagy.
Sarkar S; Rubinsztein DC
FEBS J; 2008 Sep; 275(17):4263-70. PubMed ID: 18637946
[TBL] [Abstract][Full Text] [Related]
16. Onjisaponin B derived from Radix Polygalae enhances autophagy and accelerates the degradation of mutant α-synuclein and huntingtin in PC-12 cells.
Wu AG; Wong VK; Xu SW; Chan WK; Ng CI; Liu L; Law BY
Int J Mol Sci; 2013 Nov; 14(11):22618-41. PubMed ID: 24248062
[TBL] [Abstract][Full Text] [Related]
17. Rapamycin inhibits polyglutamine aggregation independently of autophagy by reducing protein synthesis.
King MA; Hands S; Hafiz F; Mizushima N; Tolkovsky AM; Wyttenbach A
Mol Pharmacol; 2008 Apr; 73(4):1052-63. PubMed ID: 18199701
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin pre-treatment protects against apoptosis.
Ravikumar B; Berger Z; Vacher C; O'Kane CJ; Rubinsztein DC
Hum Mol Genet; 2006 Apr; 15(7):1209-16. PubMed ID: 16497721
[TBL] [Abstract][Full Text] [Related]
19. Latrepirdine stimulates autophagy and reduces accumulation of α-synuclein in cells and in mouse brain.
Steele JW; Ju S; Lachenmayer ML; Liken J; Stock A; Kim SH; Delgado LM; Alfaro IE; Bernales S; Verdile G; Bharadwaj P; Gupta V; Barr R; Friss A; Dolios G; Wang R; Ringe D; Protter AA; Martins RN; Ehrlich ME; Yue Z; Petsko GA; Gandy S
Mol Psychiatry; 2013 Aug; 18(8):882-8. PubMed ID: 22869031
[TBL] [Abstract][Full Text] [Related]
20. Yeast as a drug discovery platform in Huntington's and Parkinson's diseases.
Outeiro TF; Giorgini F
Biotechnol J; 2006 Mar; 1(3):258-69. PubMed ID: 16897706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
